the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection

Completed

• Conditions: SARS-CoV2 Infection

• Registration Number: NCT04893694
• Lead Sponsor: Fayoum University

Brief Summary

The SARS-Cov2 virus was identified in china at the end of 2019 and spread worldwide causing a global pandemic. Current research showed that SARS-Cov2 virus invades human cells via the receptor angiotensin-converting enzyme 2 (ACE2) through scRNA-seq data analyses. The study identified the organs that are at risk and are vulnerable to SARS-CoV-2 infection. Therefore, cells with ACE2 receptor distribution may become host cells for the virus and cause inflammatory response in related organs and tissues, such as the tongue mucosa and salivary glands. These results suggest that oral mucosa could be a target of SARS-CoV-2 infection

Detailed Description

The oral cavity is particularly susceptible to viral infection with several viruses such as herpes simplex virus, cytomegalovirus and Zika virus because of its structures, especially salivary glands and soft tissues . Moreover, oral mucosa can be affected by secondary pathological process of a bacterial or fungal nature due to viral immunosuppression. The oral cavity could be considered a "biological barometer" of both viral infection and viral immunosuppression advancement .

The SARS-Cov2 virus was identified in china at the end of 2019 and spread worldwide causing a global pandemic. Current research showed that SARS-Cov2 virus invades human cells via the receptor angiotensin-converting enzyme 2 (ACE2) through scRNA-seq data analyses. The study identified the organs that are at risk and are vulnerable to SARS-CoV-2 infection. Therefore, cells with ACE2 receptor distribution may become host cells for the virus and cause inflammatory response in related organs and tissues, such as the tongue mucosa and salivary glands. These results suggest that oral mucosa could be a target of SARS-CoV-2 infection .

Although many authors reported the presence of oral lesion associated with SARS-CoV2 infection, the prevalence of the oral manifestation and the range of oral manifestation are still unknown. Further studies are necessary to better understanding of the symptoms of the SARS-CoV2 virus in order to faster detection. A multidisciplinary team following the patients could be the key in treatment of the infection and faster recovery.

Study Timeline

• Study First Submitted: 2021-05-15
• Study First Submitted QC: 2021-05-15
• Study First Posted: 2021-05-19
• Study Start: 2021-05-20
• Primary Completion: 2021-06-20
• Study Completion: 2021-07-15
• Status Verified: 2021-08
• Last Update Submitted: 2021-08-21
• Last Update Posted: 2021-08-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 385

Inclusion Criteria

• A diagnosis of SARS-CoV2 with PCR.
• Age range from 18-60 years old
• Hospital admission not more than 10 days

Exclusion Criteria

• Pregnancy or contraceptive pills
• Lactation
• Any auto-immune disease that could affect the oral mucosa
• On any neoplastic therapy.
• Uncontrolled diabetes.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oral Manifestation	one week	presence or absence of Oral Manifestation in SARS-CO2

Trial Locations

Locations (1)

Faculty of Dentistry; 🇪🇬 Fayoum, Egypt